Seegene Unveils CURECA and STAgora at ADLM 2025, Advancing the Next Stage of Diagnostics
Dr. Jong-Yoon Chun, Chairman and CEO of Seegene, highlights progress toward fully…
Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D Projects With Partners Including European Vaccine Initiative, University of Copenhagen, and University of Tbingen
TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT)…
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or…
Seegene Launches STAgora, a New Platform for Infectious Disease Analytics
Real-time analytics that empower clinical decision-making and pandemic preparednessGlobal unveiling at ADLM 2025…